FDA Adverse Event Injury Summary report: N

EVOLUT PRO TRANSCATHETER AORTIC VALVE

MDR report key: 10532611 · Received September 14, 2020

Report

Report Number
2025587-2020-02827
Event Type
Injury
Date Received
September 14, 2020
Date of Event
May 1, 2020
Report Date
September 14, 2020
Manufacturer
MEDTRONIC HEART VALVES DIVISION
Product Code
NPT
PMA / PMN Number
P130021
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AZ, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

CITATION: AJMAL M., ET AL. TRANSCATHETER AORTIC VALVE REPLACEMENT IN CARDIOGENIC SHOCK WITH PERCUTANEOUS TANDEMHEART SUPPORT. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, MAY 2020; 95:S173, IV-3. EARLIEST DATE OF PUBLISH USED FOR EVENT DATE. [MEDTRONIC PRODUCTS REFERENCED: EVOLUT PRO (PMA# P130021, PRODUCT CODE: NPT). EARLIEST APPROVED PRODUCT USED FOR PRODUCT CODE AND PMA#.] NO UNIQUE DEVICE IDENTIFIER (SERIAL/LOT) NUMBERS WERE PROVIDED; WITHOUT THIS INFORMATION IT COULD NOT BE DETERMINED WHETHER THESE OBSERVATIONS HAVE BEEN PREVIOUSLY REPORTED. WITHOUT RETURN OF THE PRODUCT NO DEFINITIVE CONCLUSION CAN BE MADE REGARDING THE CLINICAL OBSERVATIONS. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

MEDTRONIC RECEIVED INFORMATION VIA LITERATURE REGARDING A (B)(6)-YEAR-OLD MALE PATIENT WITH SEVERE AORTIC STENOSIS IN CARDIOGENIC SHOCK WHO UNDERWENT IMPLANT OF A 29-MM MEDTRONIC EVOLUT PRO BIOPROSTHETIC VALVE (NO SERIAL NUMBER WAS PROVIDED). DURING IMPLANTATION, THE PATIENT DEVELOPED COMPLETE HEART BLOCK, REQUIRING TEMPORARY TRANS-VENOUS PACING AND LATER PLACEMENT OF AN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD). THE PATIENT WAS LATER DISCHARGED FROM THE HOSPITAL IN STABLE CONDITION. NO ADDITIONAL ADVERSE PATIENT EFFECTS OR PRODUCT PERFORMANCE ISSUES WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
992999 EVOLUT PRO TRANSCATHETER AORTIC VALVE AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED NPT MEDTRONIC HEART VALVES DIVISION EVOLUTPRO-23

Patients

Seq Age Sex Outcome Treatment
1 67 YR Life Threatening| R